EUVIMEDEUVIMED entdecken
Crossref

Abstract TH295: Circulating Endothelial Microparticles in Hypertension and Vascular Dysfunction

Manogyna Bontha, Aneesh Nadipelli, Imam H Shaik

Hypertension · 2026-10 · 83 (Suppl_1)

DOI: 10.1161/hyp.83.suppl_1.th295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Manogyna Bontha und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Endothelial microparticles and microvesicles (EMP/EMV) are circulating markers and mediators of endothelial injury. Their role in hypertension and blood pressure-related vascular dysfunction remains unclear. We reviewed human studies linking endothelial vesicles with hypertension, vascular dysfunction, and end-organ damage.

Methods

We searched PubMed/MEDLINE, Embase, Scopus, Web of Science, Cochrane Library, PROSPERO, and reference lists for human studies evaluating endothelial derived microparticles, microvesicles, or extracellular vesicles in adults with hypertension, prehypertension, or blood pressure-related vascular dysfunction. Searches identified 263 records; after removal of 16 duplicates, 247 were screened, 27 full texts were assessed, and 16 studies were included. We extracted data on blood pressure phenotype, vesicle markers, assay method, vascular outcomes, and risk of bias. Descriptive synthesis integrated studies with variation in vesicle phenotype, assay platform, reporting units, comparator groups, and effect-size reporting.

Results

Included studies measured several endothelial vesicle phenotypes, most commonly CD31+/annexin V+, CD144+, CD62E+, CD51+, and CD31+ phenotypes using platelet exclusion markers. Five studies included treatment or intervention designs and four focused on renal end-organ injury. Across studies, vascular outcomes ranged from arterial stiffness and central blood pressure to carotid intima-media thickness, flow-mediated dilation, and endothelial function measures. Altered EMP/EMV profiles were observed across hypertension, renal end-organ injury, arterial stiffness, and treatment-responsive vascular dysfunction. In hypertensive patients with renal injury, CD31+/annexin V+ microparticles increased across normoalbuminuria, microalbuminuria, and macroalbuminuria groups (1.8±2.2%, 3.0±4.3%, 5.2±6.2%; P=0.044) and correlated with urinary albumin excretion (r=0.417; P

Zitieren

APA

Bontha, M., Nadipelli, A., & Shaik, I. H. (2026). Abstract TH295: Circulating Endothelial Microparticles in Hypertension and Vascular Dysfunction. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th295

Vancouver

Bontha M, Nadipelli A, Shaik IH. Abstract TH295: Circulating Endothelial Microparticles in Hypertension and Vascular Dysfunction. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th295

BibTeX
@article{Bontha2026,
  author = {Bontha, Manogyna and Nadipelli, Aneesh and Shaik, Imam H},
  title = {Abstract TH295: Circulating Endothelial Microparticles in Hypertension and Vascular Dysfunction},
  journal = {Hypertension},
  year = {2026},
  volume = {83},
  number = {Suppl_1},
  doi = {10.1161/hyp.83.suppl_1.th295}
}
Kostenlos starten →